A detailed history of Nan Fung Group Holdings LTD transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Nan Fung Group Holdings LTD holds 102,984 shares of ACAD stock, worth $1.68 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares
102,984
Previous 102,984 -0.0%
Holding current value
$1.68 Million
Previous $1.67 Million 5.32%
% of portfolio
1.54%
Previous 1.95%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$17.79 - $30.86 $1.3 Million - $2.25 Million
73,000 Added 243.46%
102,984 $1.9 Million
Q1 2022

May 13, 2022

SELL
$20.94 - $27.5 $105,767 - $138,902
-5,051 Reduced 14.42%
29,984 $726,000
Q4 2021

Feb 14, 2022

BUY
$16.79 - $27.09 $588,237 - $949,098
35,035 New
35,035 $818,000

Others Institutions Holding ACAD

About ACADIA PHARMACEUTICALS INC


  • Ticker ACAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 161,843,008
  • Market Cap $2.63B
  • Description
  • ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...
More about ACAD
Track This Portfolio

Track Nan Fung Group Holdings LTD Portfolio

Follow Nan Fung Group Holdings LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nan Fung Group Holdings LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nan Fung Group Holdings LTD with notifications on news.